Suppr超能文献

70 岁以上终末期肾病患者血管通路的比较结果。

Comparative outcomes of vascular access in patients older than 70 years with end-stage renal disease.

机构信息

Division of Vascular Surgery, Department of Surgery, Kyungpook National University Hospital, Daegu, South Korea.

Division of Vascular Surgery, Department of Surgery, Kyungpook National University Hospital, Daegu, South Korea.

出版信息

J Vasc Surg. 2019 Apr;69(4):1196-1206.e5. doi: 10.1016/j.jvs.2018.07.061. Epub 2018 Oct 24.

Abstract

OBJECTIVE

The advantage of arteriovenous fistulas (AVFs) in older patients requiring dialysis is controversial. We reviewed our vascular access experience in patients ≥70 years of age (older group) compared with younger patients.

METHODS

We analyzed consecutive patients who underwent access surgery between 2013 and 2016. Primary success (PS) and primary patency (PP) data were analyzed between the older and younger groups before and after propensity score matching of the patients' characteristics and access composition. PS was defined as the achievement of access function that was amenable to two sessions of successful cannulation without early occlusion or maturation failure requiring revision. PP was defined as the time with uninterrupted patency without intervention.

RESULTS

A total of 594 consecutive accesses were created among 563 patients, of whom 119 were allocated into each group after propensity score matching. In the whole cohort, 193 accesses (32.5%) were performed in older patients. AVFs were performed in 130 (67.4%) older patients and 293 (73.1%) younger patients. Regarding AVFs, the PS rate (83.6% in the older group vs 94.3% in the younger group; P = .001) and the overall PP at 6 and 12 months (73.1% and 57.1%, respectively, in the older group vs 86.7% and 77.7%, respectively, in the younger group; P = .009) were lower in the older group than in the younger group. However, no differences were found in the PS and PP rates for arteriovenous grafts between groups. Regarding the AVF location, the PS rate for forearm AVFs was significantly lower in the older group than in the younger group (76% vs 93%; P < .001); however, the PS rate of the upper arm was not different between the groups (94% vs 97%; P = .425). In the patients with PS, the PP rate of AVFs was similar between the two groups. In the older group with forearm AVFs, the median diameter of the radial artery was larger in the patients with PS than in the patients without PS (2.20 mm with PS vs 2.00 mm without PS; P = .008). The propensity score matching results demonstrated similar trends for the whole cohort, with lower PS (P = .042) and PP rates (P = .023) for AVF in the older group.

CONCLUSIONS

The outcomes after AVF were poorer in the older group than in the younger group, which was primarily due to unsatisfactory outcomes in patients with forearm AVFs. Thus, stricter criteria, especially regarding the radial artery diameter, should be applied for forearm AVFs in older patients, and additional research is necessary to delineate the risk factors for primary failure.

摘要

目的

在需要透析的老年患者中,动静脉瘘(AVF)的优势存在争议。我们回顾了我们在≥70 岁(老年组)患者中的血管通路经验,并与年轻患者进行了比较。

方法

我们分析了 2013 年至 2016 年期间接受通路手术的连续患者。在对患者特征和通路构成进行倾向评分匹配后,比较了老年组和年轻组之间的初次通畅(PS)和初次通畅率(PP)数据。PS 定义为实现可进行两次成功穿刺的通路功能,且无早期闭塞或成熟失败需要修复。PP 定义为无干预的连续通畅时间。

结果

在 563 名患者中,共建立了 594 个通路,其中 119 个在倾向评分匹配后被分配到每组。在整个队列中,193 个通路(32.5%)在老年患者中进行。130 例(67.4%)老年患者和 293 例(73.1%)年轻患者进行了 AVF。关于 AVF,老年组的 PS 率(83.6%比年轻组的 94.3%;P=0.001)和 6 个月和 12 个月的总体 PP 率(分别为 73.1%和 57.1%,老年组和 86.7%和 77.7%,年轻组;P=0.009)均低于年轻组。然而,两组之间动静脉移植物的 PS 和 PP 率没有差异。关于 AVF 的位置,老年组前臂 AVF 的 PS 率明显低于年轻组(76%比 93%;P<0.001);然而,两组之间上臂的 PS 率没有差异(94%比 97%;P=0.425)。在 PS 的患者中,两组之间的 PP 率相似。在老年组前臂 AVF 中,PS 患者的桡动脉直径大于无 PS 患者(PS 患者 2.20mm 比无 PS 患者 2.00mm;P=0.008)。倾向评分匹配结果表明,在整个队列中也存在类似的趋势,老年组的 PS(P=0.042)和 PP 率(P=0.023)较低。

结论

与年轻组相比,老年组 AVF 后的结果较差,这主要是由于前臂 AVF 患者的结果不理想。因此,对于老年患者的前臂 AVF,应采用更严格的标准,特别是桡动脉直径标准,还需要进一步研究以确定原发性失败的危险因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验